Biotech

All Articles

Lilly- backed weight loss biotech reports IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' marijuana make use of medicine fails phase 2b, driving Indivior to re-think $100M choice

.Aelis Farma's chances of protecting a fast, favorable choice on a $one hundred thousand option repa...

ProKidney standstills phase 3 trial not needed for cell therapy approval

.ProKidney has actually ceased some of a set of period 3 trials for its own cell treatment for kidne...

Vaxcyte climbs on 'stunning' 31-valent PCV win versus Pfizer

.Vaxcyte introduced what experts named "impressive" stage 1/2 records for its 31-valent pneumococcal...

Recursion's human brain disease trial shows little evidence of effectiveness

.Recursion has actually stumbled through a very early test of its tech-enabled strategy to medicatio...

Acepodia, Pfizer click with each other for chemistry-based cell therapy

.Phone it an instance of excellent chemical make up: Acepodia, a biotech based upon Nobel Prize-winn...

Praxis epilepsy medicine lessens seizures in period 2 litigation

.Practice Precision Medicines has actually racked up an additional midphase win in epilepsy this yea...

Three officers resign as Dyne messages combined records for DMD applicant

.After escaping a scientific grip numerous years back, Dyne Therapeutics has shown new stage 1/2 dat...

Arrowhead fires off phase 3 data in unusual metabolic condition ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its hand in advance of a prospective showdown along with Ionis,...

Pfizer, Valneva present lyme disease chance successful for 2nd enhancer

.Pfizer and Valneva might possess concerning two additional years to wait just before they produce t...